Content by Keyword: Equipment and Supplies

  • Home
  • Equipment and Supplies
  • print
  • email
  • twitter
  • compact
Report page
“PROTECTING OUR HOMELAND”

Performance Improvement 2005. “Protecting Our Homeland”

GOAL 2: Enhance the ability of the Nation’s health care system to effectively respond to bioterrorism and other public health challenges Objective2.1 Build the capacity of the health care system to respond to public health threats in a more timely and effective manner, especially bioterrorism threats Objective2.2 Improve the safety of food
Report page
Objective 2.2 - Improve the Safety of Food, Drugs

Performance Improvement 2004. Objective 2.2 - Improve the Safety of Food, Drugs, Biological Products, and Medical Devices

Report page
APPENDIX C – LIST OF STUDIES BY AGENCY

Performance Improvement 2006. Appendix C – List of Studies by Agency

AGENCY ID TITLE G/O OBJECTIVE PROJECT OFFICER ACF-ACYF 8221 Synthesis of Findings: Title IV-E Flexible Funding Child Welfare Waiver Demonstrations 7.4 Increase the percentage of children and youth living in a permanent, safe environment Collins, Gail E. ACF-ACYF 8220
Report page
FOOD AND DRUG ADMINISTRATION

Performance Improvement 2006. Food and Drug Administration

Mission To protect the public health by assuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, our nation’s food supply, cosmetics, and products that emit radiation; to advance public health by helping to speed innovations that make medicines and foods more effective, safer, and a
Report page
“PROTECTING OUR HOMELAND”

Performance Improvement 2006. “Protecting Our Homeland”

GOAL 2: Enhance the ability of the Nation’s health care system to effectively respond to bioterrorism and other public health challenges Objective 2.1
Report page
OBJECTIVE 2.2 - IMPROVE THE SAFETY OF FOOD, DRUGS

Performance Improvement 2005. Objective 2.2 - Improve the Safety of Food, Drugs, Biological Products, and Medical Devices

Report page
Office of Policy, Planning and Legislation

Performance Improvement 2003. Office of Policy, Planning and Legislation

Assessment of the Availability of Mammography Services
Report page
Mission

Performance Improvement 2003. Mission

The FDA is responsible for protecting the public health by assuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, our nation's food supply, cosmetics, and products that emit radiation. The FDA is also responsible for advancing the public health by helping to speed innovations that make medi
Report page
Objective 2.2 - Improve the Safety of Food, Drugs

Performance Improvement 2006. Objective 2.2 - Improve the Safety of Food, Drugs, Biological Products, and Medical Devices

Report
Performance Improvement 2003

Performance Improvement 2003

Performance Improvement 2003: Evaluation Activities of the U.S. Department of Health and Human Services is the ninth annual report to Congress summarizing prior fiscal year evaluation efforts. The purpose of this report is to provide Congress with outcome-oriented evaluation findings for the Department’s programs, policies, and strategies. The re
  • pi_2003.pdf
    export-csvPDF
Report
The Feasibility of Using Electronic Health Data

The Feasibility of Using Electronic Health Data for Research on Small Populations

Background. Many small populations have distinctive health and health care needs but have been difficult to study in survey research. Objective. This report is part of a project funded by the Assistant Secretary for Planning and Evaluation to explore the feasibility of using electronic health record (EHR) and other electronic health data for resea
  • rpt_ehealthdata.pdf
    export-csvPDF
Report
Pie Chart: It helped a lot (75%); It helped a

Accelerating Adoption of Assistive Technology to Reduce Physical Strain among Family Caregivers of the Chronically Disabled Elderly Living at Home

This report examines and assesses the often overlooked potential of assistive technology (AT) to benefit unpaid family caregivers who assist chronically disabled elders living at home. Although research has identified benefits, only a handful of publicly-funded family caregiver support programs give much attention to enabling caregivers’ access
  • AccAdoAT.pdf
    export-csvPDF
Report
Examination of Clinical Trial Costs and Barriers

Examination of Clinical Trial Costs and Barriers for Drug Development

Pharmaceutical companies conduct clinical trials for many reasons. The most obvious goal of clinical trials is to demonstrate safety and efficacy to gain Food and Drug Administration (FDA) approval. FDA provides guidance to developers about what constitutes acceptable clinical trials and appropriate outcomes. Improving the drug development process
  • rpt_erg.pdf
    export-csvPDF
Report
Analytical Framework for Examining the Value of

Analytical Framework for Examining the Value of Antibacterial Products

Antibacterial resistance is a growing global problem.  At least 2 million people in the U.S. acquire serious infections with bacteria that are resistant to one or more of antibacterial drugs designed to treat it.  Despite the potential of new antibacterial products to reduce the social burden associated with resistant infections, development of
  • rpt_antibacterials.pdf
    export-csvPDF
Report
Diabetes: A National Plan for Action

Diabetes: A National Plan for Action

Currently, more than 18 million Americans have diabetes and are at risk for related complications like heart disease, stroke, blindness, amputations, and kidney disease. This document provides up-to-date and accurate prevention, detection, and treatment information, and includes simple action steps for individuals, families, health practitioners,
  • NDAP04.pdf
    export-csvPDF
Report
Performance Improvement 2009 and program

Performance Improvement 2009

This report fulfills a statutory obligation of the Department of Health and Human Services. Section 241 of the Public Health Service Act directs the Secretary to inform Congress annually concerning findings from evaluations conducted by the Department. As required, the report is submitted to the Senate Health, Education, Labor and Pensions Committ
  • PerformanceImprovement2009.pdf
    export-csvPDF
Report
Performance Improvement 2008

Performance Improvement 2008

This Performance Improvement series of reports takes its name from the primary goal of carrying out evaluations – to improve the performance of programs meant to serve the greatest needs of the community. Performance Improvement 2008, the latest of these reports, makes available the most recently completed evaluations of the Department of Health
  • PerformanceImprovement2008.pdf
    export-csvPDF
Report
Performance Improvement 2007

Performance Improvement 2007

This Performance Improvement 2007 report provides a brief summary of each of the evaluations completed by the Health and Human Services (HHS) during Fiscal Year 2006 (October 1, 2005 to September 30, 2006). All Performance Improvement reports, the full database of summaries or abstracts of the more than 8,000 current, ongoing, and past studies, an
  • PerformanceImprovement2007.pdf
    export-csvPDF
Report
Performance Improvement 2006

Performance Improvement 2006

This Performance Improvement 2006 report presents to Congress a comprehensive summary of evaluation projects completed by the Department, The Office of the Secretary, and agencies comprising the Department, engage in extensive evaluation activities; some are required by statute, while others are determined to be essential by an individual agency, t
  • pi_2006.pdf
    export-csvPDF
Report
Performance Improvement 2005

Performance Improvement 2005

Performance Improvement 2005: Evaluation Activities of the U.S. Department of Health and Human Services, complies with Section 241(b) of the Public Health Service Act, as amended by the Preventive Health Amendments of 1993. This is the 11th annual report to Congress. Performance Improvement 2005 provides results-oriented findings regarding the Depa
  • pi_2005.pdf
    export-csvPDF

Pages

Form Approved OMB# 0990-0379 Exp. Date 9/30/2020